The body’s immune system is a valiant weapon against disease, and harnessing its power through a technique called immunotherapy is at the forefront of current research to treat cancer and other diseases. That’s why an unexpected finding by Notre Dame researchers and their collaborators, related to the way two distinctively different peptide antigens react with one T-cell receptor, tosses a new wrench into the process of building better molecules to develop immunotherapies.
All are invited to attend the annual ND-Purdue Symposium on Soft Matter and Polymers. Hosted by the University of Notre Dame and Purdue University, the event will take place at Notre Dame’s McCourtney Hall on Saturday, October 6 from 8:15 a.m. to 5:45 p.m. EDT.
Each year, grants from the Discovery Fund are awarded to researchers who propose novel technologies and diagnostics that can improve human and environmental health.
Indiana University, Purdue University, and the University of Notre Dame invite all researchers to attend the Indiana Clinical and Translational Sciences Institute (CTSI) retreat. The event will take place at the University of Notre Dame’s McCourtney Hall on Friday, October 26, 2018 from 9:00 a.m. to 4:15 p.m.
The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe. Results from the research of Jeff W. Peng, associate professor of chemistry and biochemistry, could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.
Chen Dai, University of Notre Dame graduate student of chemistry and biochemistry, was recognized at the Indiana University (IU) Simon Cancer Center’s annual Cancer Research Day. Dai received first prize for his poster presentation in the basic science – graduate student category.